Sagimet Biosciences (SGMT) Current Assets (2022 - 2026)
Sagimet Biosciences' Current Assets was $243.99 million in Q2 2026, up 91.8% from $127.2 million a year earlier and up 126.5% from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Sagimet Biosciences came in at $116.4 million, down 23.8% from FY2024.
- Current Assets shows a three-year compound annual growth rate of 52.5% (FY2022 to FY2025).
- In earlier years, Current Assets was $152.77 million in FY2024 (+58.1%), $96.65 million in FY2023 (+194.7%) and $32.79 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Current Assets in data going back to Q4 2022.
- Compared with a year earlier, Current Assets was higher in three of the last eight quarters, with growth averaging 10.0%.
- The best year-over-year quarter for Current Assets over five years was Q2 2024 (growth of 680.9%); the worst was Q1 2026 (a decline of 26.3%).
- Per Business Quant data, SGMT's Current Assets in the three quarters before Q2 2026 was $107.72 million (Q1 2026), $116.4 million (Q4 2025) and $119.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Sagimet Biosciences | 529.82 Mn | -44.67 Mn | - | 243.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 243.99 Mn |
| Mar 31, 2026 | 107.72 Mn |
| Dec 31, 2025 | 116.40 Mn |
| Sep 30, 2025 | 119.48 Mn |
| Jun 30, 2025 | 127.20 Mn |
| Mar 31, 2025 | 146.07 Mn |
| Dec 31, 2024 | 152.77 Mn |
| Sep 30, 2024 | 157.19 Mn |
| Jun 30, 2024 | 166.75 Mn |
| Mar 31, 2024 | 194.49 Mn |
| Dec 31, 2023 | 96.65 Mn |
| Sep 30, 2023 | 102.82 Mn |
| Jun 30, 2023 | 21.35 Mn |
| Dec 31, 2022 | 32.79 Mn |
API Access
Sagimet Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();